The Clinical and Economic Value of a Successful Shutdown During the SARS-CoV-2 Pandemic in Germany
Afschin Gandjour
doi: https://doi.org/10.1101/2020.05.12.20098996
Afschin Gandjour
1Frankfurt School of Finance & Management, Frankfurt, Germany
MD, PhD, MAData Availability
All data analyzed are publicly available.
Posted August 06, 2020.
The Clinical and Economic Value of a Successful Shutdown During the SARS-CoV-2 Pandemic in Germany
Afschin Gandjour
medRxiv 2020.05.12.20098996; doi: https://doi.org/10.1101/2020.05.12.20098996
Subject Area
Subject Areas
- Addiction Medicine (404)
- Allergy and Immunology (713)
- Anesthesia (208)
- Cardiovascular Medicine (2975)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12834)
- Forensic Medicine (12)
- Gastroenterology (834)
- Genetic and Genomic Medicine (4631)
- Geriatric Medicine (425)
- Health Economics (733)
- Health Informatics (2947)
- Health Policy (1074)
- Hematology (394)
- HIV/AIDS (935)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4425)
- Nursing (238)
- Nutrition (653)
- Oncology (2300)
- Ophthalmology (654)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (85)
- Pathology (503)
- Pediatrics (1201)
- Primary Care Research (504)
- Public and Global Health (7017)
- Radiology and Imaging (1552)
- Respiratory Medicine (923)
- Rheumatology (446)
- Sports Medicine (386)
- Surgery (492)
- Toxicology (60)
- Transplantation (213)
- Urology (185)